Filter
202
Filtered Results: 202
Text search:
buruli
ulcer
Featured
Recommendations
16
New Publications
35
Language
Document type
No document type
72
Studies & Reports
49
Guidelines
25
Strategic & Response Plan
13
Manuals
12
Videos
7
Resource Platforms
6
Fact sheets
6
Brochures
5
Training Material
3
Infographics
3
Online Courses
1
Countries / Regions
Global
26
Benin
11
Ghana
7
Liberia
6
Togo
5
Nigeria
4
Congo, Democratic Republic of
4
Africa
3
Sierra Leone
2
Cameroon
2
Syria
2
Iran
2
Jordan
2
Germany
2
Saudi Arabia
2
Western and Central Europe
2
Lebanon
2
Sudan
2
Iraq
2
Pakistan
2
Kenya
1
Albania
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Morocco
1
Qatar
1
Middle East and North Africa
1
Tunisia
1
Uganda
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Libya
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Buruli Ulcer
24
Policies
18
Studies & Reports
12
NTDs & Others
10
Dermatology
7
Statistics
7
Public Health
4
Bacteriology
4
Guidelines
4
Leprosy
4
Disease Prevention & Control
4
Drugs & Medical Equipment
3
Other
3
Primary Health Care
3
Leishmaniasis
3
Non-communicable Diseases
3
Communicable Diseases
2
Helminthiasis
2
Yaws
2
Community Health
2
Countries
2
Policies & Guidelines HIV & TB
2
Community Health
2
Capacity Building
2
WASH
2
Surgery & Anaesthesia
2
Communicable Diseases
2
Health Systems
2
TB
2
Pharmacy & Technology
1
Child Health
1
Trachoma
1
Online Courses & Platforms
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Neglected Tropcial Diseases NTDs
1
Public Health
1
Health System Strengthening
1
Chagas
1
Diarrhoeal Disease/Cholera
1
Clinical Guidelines
1
Yellow Fever
1
Demograhic Health Surveys DHS
1
Information, Education and Communication (IEC)
1
Disabilities
1
General Guidelines
1
Parasitology
1
Laboratory Technologies
1
HIV & STI
1
Physiotherapy & Rehabilitation
1
Toolboxes
Information & Education Material (IEC)
25
Clinical Aspects & Diagnostics
24
Studies & Reports
16
Capacity Building & Resources
13
Disability Prevention & Rehabilitation
10
Overview, Studies & Reports
9
Community Health Workers CHW
8
Statistics & Facts
8
Surveillance
5
Others
5
Studies & Reports
4
NTDs General
4
Prevention of Disabilites
4
Policies & Strategies
3
Strategies & Roadmaps
3
Capacity Building & Resource platforms
3
Yaws & other Endemic Treponematoses
3
Nigeria
3
One Health
2
Buruli Ulcer
2
Mycetoma, Chromoblastomycosis & other deep mycosis
2
Onchocerciasis
2
Snakebite envenoming
2
Diagnosis
2
Germany
2
Local Action
1
Clinical Guidelines
1
Vaccines & Immunization
1
Yellow Fever
1
Prevention & Control
1
Surgery & Rehabilitation
1
Adults
1
Introduction to Global Health
1
WASH
1
National Policies
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Prevention & Control
1
Physiotherapy & Rehabilitation
1
Studies
1
Hospital Readiness/Essential Health Services
1
RCCE Guides & Manuals
1
At Home
1
Ecuador
1
Rational use of Medicine
1
HIV &TB
1
Zoonoses
1
Health Impact & Climate Change
1
NTDs
1
Leishmaniasis
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Vector control
1
General Information & Methodology
1
Community Based Rehabilitation (CBR)
1
Studies & Reports
1
General
1
Ghana
1
Assistive devices & technologies
1
Community Worker
1
Disease Prevention & Control
1
Training
1
Research & Access
1
TB/HIV Coinfection
1
TB
1
Universal Health Coverage & Primary Health Care
1
Public Health
1
Treatment & Clinical Management
1
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
Volume 2016 | Article ID 5310718 | https://doi.org/10.1155/2016/5310718. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss li...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the M...
PLoS Negl Trop Dis 5(6): e1187. doi:10.1371/journal.pntd.0001187. Buruli ulcer (BU), caused by Mycobacterium ulcerans infection, is a debilitating disease of the skin and underlying tissue which starts as a painless nodule, oedema or plaque and could develop into painful and massive ulcers if left u...
Buruli ulcer is caused by infection with Mycobacterium ulcerans. The disease is reported in more than 33 countries worldwide, but only about half of these countries regularly report data to WHO; most cases are reported from subregions of West and Central Africa. The mode of transmission is not known...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
This course is intended to provide basic information for front-line health workers to be able to implement the recommended control measures to minimize the negative impact of Buruli ulcer on populations.
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A...
This manual is to assist health care providers and laboratory scientists to diagnose mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the clinical presentation and its diagnosis. The methods described are tailored to various levels of care and avail...
A guide for field health workers
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
In 2009, WHO’s Second International Conference on Buruli Ulcer Control and Research resolved to strengthen the capacity of national laboratories to confirm cases of the disease, but advised that “efforts are still needed to develop simple diagnostic tools usable in the field as well as disabilit...
Buruli ulcer mostly affects children. This comic is aimed at giving them a better knowledge of the disease.
Website last accessed on 18.03.2023
